High-level expression of Hsp90β is associated with poor survival in resectable non-small-cell lung cancer patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-level expression of Hsp90β is associated with poor survival in resectable non-small-cell lung cancer patients
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 67, Issue 4, Pages 509-519
Publisher
Wiley
Online
2015-02-23
DOI
10.1111/his.12675
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors
- (2014) H Engerud et al. BRITISH JOURNAL OF CANCER
- Ganetespib and HSP90: Translating Preclinical Hypotheses into Clinical Promise
- (2014) D. A. Proia et al. CANCER RESEARCH
- The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
- (2014) Ruth Scherz-Shouval et al. CELL
- Co-overexpression of Hsp90-β and annexin A1 with a significantly positive correlation contributes to the diagnosis of lung cancer
- (2014) Rong Biaoxue et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non-Small Cell Lung Cancer
- (2013) M. A. Socinski et al. CLINICAL CANCER RESEARCH
- Network Analysis Identifies an HSP90-Central Hub Susceptible in Ovarian Cancer
- (2013) H. Liu et al. CLINICAL CANCER RESEARCH
- Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer
- (2013) D. A. Proia et al. CLINICAL CANCER RESEARCH
- HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers
- (2012) Marc L. Mendillo et al. CELL
- Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
- (2012) David A. Proia et al. INVESTIGATIONAL NEW DRUGS
- Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients
- (2012) Rong Biaoxue et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Evidence of Prognostic Relevant Expression Profiles of Heat-Shock Proteins and Glucose-Regulated Proteins in Oesophageal Adenocarcinomas
- (2012) Julia Slotta-Huspenina et al. PLoS One
- Heat Shock Protein 90 Inhibition in Lung Cancer
- (2010) Takeshi Shimamura et al. Journal of Thoracic Oncology
- Targeting HSP90 for cancer therapy
- (2009) D Mahalingam et al. BRITISH JOURNAL OF CANCER
- HSP90 Inhibitors: Multi-Targeted Antitumor Effects and Novel Combinatorial Therapeutic Approaches in Cancer Therapy
- (2009) Misun Hwang et al. CURRENT MEDICINAL CHEMISTRY
- Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas
- (2008) Hua-chuan Zheng et al. HUMAN PATHOLOGY
- The Hsp90 Chaperone Machinery
- (2008) Sebastian Karl Wandinger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now